Alliance Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alliance Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (476)	5/12/2000 11:16:00 AM
From: All Mtn Ski	Read Replies (2) of 548

Taking an equity stake in ALLP is standard practice when any deal is announced. JNJ still has 3 million shares at $15 from their Oxygent deal a few years ago. I presume JNJ still holds the shares. Milestone payments usually follow after the initial deal, and Oxygent is in stage 3 trials, so there may not be that many "milestones" left before submission to the FDA. It looks like ALLP is suffering from a little "Sell on the news". Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next